Evidence map›Paper›PMID 25490766›Full record

ArticlePloS one2014

Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.

Fei Dong, Humayun Irshad, Eun-Yeong Oh, Melinda F Lerwill, Elena F Brachtel, Nicholas C Jones, Nicholas W Knoblauch, Laleh Montaser-Kouhsari, Nicole B Johnson, Luigi K F Rao and 4 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Artificial intelligence applied to breast pathology.Virchows Archiv : an international journal of pathology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Improving DCIS diagnosis and predictive outcome by applying artificial intelligence.Biochimica et biophysica acta. Reviews on cancer · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Derivation of a nuclear heterogeneity image index to grade DCIS.Computational and structural biotechnology journal · 2020
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Fei DongDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Humayun IrshadDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Eun-Yeong OhDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Melinda F LerwillDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Elena F BrachtelDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Nicholas C JonesDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Nicholas W KnoblauchDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Laleh Montaser-KouhsariDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Nicole B JohnsonDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Luigi K F RaoDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Beverly Faulkner-JonesDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
David C WilburDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Stuart J SchnittDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Andrew H BeckDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Harvard University · USMassachusetts General Hospital · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · US

Funding

Tissue and Pathology CoreP50CA168504 · NCI · DANA-FARBER CANCER INST · PI Geoffrey I. Shapiro · 2013 to 2026
$30.1M
INFORMATICS METHODS AND MODELS FOR COMPUTATIONAL PATHOLOGYK22LM011931 · NLM · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BECK, ANDREW H · 2014 to 2016
$476k
NCI NIH HHS P50 CA168504NLM NIH HHS K22 LM011931NLM NIH HHS K22LM011931
6 · The paper itself

Abstract

The categorization of intraductal proliferative lesions of the breast based on routine light microscopic examination of histopathologic sections is in many cases challenging, even for experienced pathologists. The development of computational tools to aid pathologists in the characterization of these lesions would have great diagnostic and clinical value. As a first step to address this issue, we evaluated the ability of computational image analysis to accurately classify DCIS and UDH and to stratify nuclear grade within DCIS. Using 116 breast biopsies diagnosed as DCIS or UDH from the Massachusetts General Hospital (MGH), we developed a computational method to extract 392 features corresponding to the mean and standard deviation in nuclear size and shape, intensity, and texture across 8 color channels. We used L1-regularized logistic regression to build classification models to discriminate DCIS from UDH. The top-performing model contained 22 active features and achieved an AUC of 0.95 in cross-validation on the MGH data-set. We applied this model to an external validation set of 51 breast biopsies diagnosed as DCIS or UDH from the Beth Israel Deaconess Medical Center, and the model achieved an AUC of 0.86. The top-performing model contained active features from all color-spaces and from the three classes of features (morphology, intensity, and texture), suggesting the value of each for prediction. We built models to stratify grade within DCIS and obtained strong performance for stratifying low nuclear grade vs. high nuclear grade DCIS (AUC = 0.98 in cross-validation) with only moderate performance for discriminating low nuclear grade vs. intermediate nuclear grade and intermediate nuclear grade vs. high nuclear grade DCIS (AUC = 0.83 and 0.69, respectively). These data show that computational pathology models can robustly discriminate benign from malignant intraductal proliferative lesions of the breast and may aid pathologists in the diagnosis and classification of these lesions.

Indexed as

Computational BiologyBreastBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingFemaleHumansHyperplasiaImage Processing, Computer-AssistedNeoplasm GradingPrognosisROC Curve

Identifiers

PMID25490766
PMCPMC4260962
OpenAlexW2115521901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.